You are here

  • Home
  • Archive
  • Volume 11, Issue 5
  • Clopidogrel plus aspirin did not differ from aspirin alone for reducing MI, stroke, and CV death in high risk atherothrombosis

Article Text

Article menu
Download PDFPDF
Therapeutics
Clopidogrel plus aspirin did not differ from aspirin alone for reducing MI, stroke, and CV death in high risk atherothrombosis

https://doi.org/10.1136/ebm.11.5.143

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • ↵* See glossary.

    • ↵† Information provided by author.

    • For correspondence: Dr E J Topol, Case Western Reserve University, Cleveland, Ohio, USA. eric.topol{at}case.edu

    • Sources of funding: Sanofi-Aventis; Bristol-Myers Squibb; National Institutes of Health.

    Linked Articles

    • Glossary
      Glossary
      BMJ Publishing Group Ltd
      BMJ Evidence-Based Medicine 2006; 11 159a-159a Published Online First: 29 Sep 2006. doi: 10.1136/ebm.11.5.159a